Bacteria

Mosquito
#Bacteria #GSK #Malaria

Newly-discovered bacteria could prevent malaria

Research published in Science shows that a naturally occurring bacterium discovered by GSK scientists – Delftia tsuruhatensis Tres Cantos 1 (TC1) – could be the basis for new anti-malarial interventions. Studies done in collaboration at the Johns Hopkins Malaria Research Institute show that the bacterium can… Read More

#News

#Bacteria #Biotherapeutics #Drug discovery #Gut microbiome

Harnessing the microbiome: The new frontier in drug discovery and testing 

Paul Denslow, CEO, Intus Bio, discusses how a new approach to tracking gut bacteria can revolutionse our understanding of the microbiome and bring about new discoveries for therapeutics.   It’s a long-held doctrine that there's no effective method to track the microbiome during drug research and development. This doctrine no longer… Read More

#Exclusive Content

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #University of Gothenburg

Study identifies previously unknown antibiotic resistance genes

Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realised. A new study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in almost all environments carry resistance genes. “We… Read More

#News

#Antimicrobial resistance (AMR) #Bacteria #Gedea Biotech #US patent

US-patent for Swedish bacterial vaginosis therapy

The United States Patent and Trademark Office (USPTO) has granted Gedea Biotech’s patent application 16/753,899 directed to gluconic acid derivatives for preventing and/or treating bacterial infections. The patent can be kept in force until 2038. The specific derivative Glucone-delta lactone (GDL) in pHyph is a well-documented… Read More

#News

Older adult receiving vaccine
#Bacteria #Immunology / Virology & Vaccines #MinervaX #Phase I trial #Vaccine candidate

Trials of Group B Streptococcus vaccine extended to older adults

Danish biotech MinervaX has launched the first Phase I clinical study in older adults of its novel Group B Streptococcus (GBS) vaccine, at CEVAC (Centre for Vaccinology) in Ghent, Belgium. GBS is a global unmet medical burden and can cause serious illness in people of all… Read More

#News

Pseudomonas aeruginosa bacteria
#Bacteria #Clinical trial #Infex Therapeutics #Lung disease #Phase I trial

Encouraging results for RESP-X in ongoing Phase I clinical trial

RESP-X, Infex Therapeutics’ anti-virulence therapy to treat Pseudomonas aeruginosa (Pa) infections in non-cystic fibrosis bronchiectasis (NCFB) patients, has shown a promising interim safety and tolerability profile in its ongoing first-in-human Phase I clinical trial. The first cohort consisted of eight healthy volunteers who received doses of… Read More

#News

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Sepsis #University of Queensland

Australian sepsis study to power new antibiotic discoveries

University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Professor Mark Walker and Professor Mark Schembri from UQ’s Institute for Molecular Bioscience, along with Dr Andre Mu from the University of… Read More

#Editor's Choice #News

Genetically engineering virus in the lab
#Bacteria #Genetic editing #Genetic engineering #Harvard Medical School #Immunology / Virology & Vaccines #RNA

Scientists engineer safe, virus-resistant E coli for research

In a step forward for genetic engineering and synthetic biology, US researchers have modified E coli bacteria to be immune to infection by all natural viruses tested so far. The team used two safeguard methods to prevent the bacteria and their modified genes from escaping into… Read More

#Editor's Choice #News

Dr Edo Kon
#Antibiotic resistance #Antimicrobial resistance (AMR) #Bacteria #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

mRNA vaccine 100% effective against deadly bacteria

For the first time, researchers have developed an mRNA vaccine that is 100% effective against a type of bacteria that is lethal to humans, paving the way for effective vaccination against antibiotic-resistant bacteria. The study, conducted in an animal model, demonstrated that all treated animals were… Read More

#News #Trending News

E coli bacteria
#Anti-inflammatory #Bacteria #Immune response #Immune system #Molecular Biology #mRNA #Preclinical investigations

Scientists use mRNA to reprogramme the immune system

University of Queensland researchers have identified a pathway in cells that could be used to reprogramme the body’s immune system to fight back against both chronic inflammatory and infectious diseases. Dr Kaustav Das Gupta and Professor Matt Sweet from UQ’s Institute for Molecular Bioscience discovered that a molecule… Read More

#News

Bacteria
#Bacteria #Cancer research #everImmune #Oncology #Phase I trial

Oncobiotic cancer drug could be a step forward for science

The first patient has been treated in everImmune’s Phase I clinical trial evaluating its oncobiotic drug candidate Oncobax AK in lung and kidney cancer patients.  The aim of the trial is to assess the toxicity and efficacy of Oncobax AK when administered alongside an immunotherapy treatment. … Read More

#Cancer Research #News

#Bacteria #Gastrointestinal #Gut microbiome #Immunity

US researchers decipher how one gut bacterium influences immunity

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease. But with hundreds of bacterial species populating our gastrointestinal tract, it’s a daunting task to pinpoint which molecules made by which bacteria affect which biological processes—and… Read More

#News

#Bacteria #High Throughput

Learn about automated high-throughput transformation of bacteria cells

In this technical guide from Analytik Jena you will learn about: The fully automated method for the high-throughput transformation and growth of bacteria cells How to improve robustness and reproducibility of your experiments How the transformation of DNA into bacteria cells, such as Escherichia coli (E. coli),… Read More

#News

#Amino acids #Bacteria #Research

Scientists engineer bacteria for more robust biotechnologies 

Researchers from the Universities of Bristol and Hamburg have engineered bacteria with internal nutrient reserves that can be accessed when needed to survive extreme environmental conditions. The findings pave the way for more robust biotechnologies based on engineered microbes.  The challenge  Dr Thomas Gorochowski, joint… Read More

#News

#Bacteria #Drug discovery #Research

‘Last resort’ antibiotic pops bacteria like balloons

Scientists have revealed how an antibiotic of ‘last resort’ kills bacteria. The findings, from Imperial College London and the University of Texas, may also reveal a potential way to make the antibiotic more powerful. The antibiotic colistin has become a last resort treatment for infections caused by superbugs. However, despite… Read More

#News

#Antibody #Bacteria #Drug development #Drug discovery #Research study

New model can predict how bacteria develop antibiotic resistance

Using theoretical models of bacterial metabolism and reproduction, scientists can predict the type of resistance that bacteria will develop when they are exposed to antibiotics. This has now been shown by an Uppsala University research team, in collaboration with colleagues in Cologne, Germany. The study is published in the journal… Read More

#News